Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study.

Support Care Cancer · 2015 · PMC4519584 · PMID 26081597

Europe PMC DOI

hedged sentence

0.7270

closest p · 14.5× alpha

0.7270

boldest claim

The sentences

did not reach statistical significancep = 0.7270not close (p > 0.1)

Particularly, the overall incidence of nausea and vomiting in patients received XELOX regimens and patients received other regimens did not reach statistical significance (42.9 vs. 45.3 %; p = 0.7270; chi-square test).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.